Description:
H.R. 1492 would authorize the Department of Justice (DOJ) to register physicians who, under certain circumstances, are permitted to transport and dispense controlled substances at locations other than their principal place of business. Under the act, DOJ would collect additional registration fees from those physicians (most already are registered and pay registration fees of a few hundred dollars per year, on average). Such fees are treated as reductions in direct spending, and DOJ is authorized to spend them without further appropriation.
Because enacting the legislation would affect direct spending, pay-as-you-go procedures apply. However, CBO estimates that the net budgetary effect would be negligible. Enacting the legislation would not affect revenues.
CBO estimates that enacting the legislation would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2029.
H.R. 1492 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal governments.
